DPIIT recognised startup Government of India
Startup India
Cellf Therapeutics Private Limited - life sciences in Bangalore, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2024
₹6.12 Lakh
▲ 920% YoY
Net loss · FY 2024
₹20.13 Lakh
Net margin -328.9%
EBITDA · FY 2024
-₹20.13 Lakh
EBITDA margin -328.9%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹33.5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Brands
1
Associated brands
About Cellf Therapeutics Private Limited
Data last updated:
Cellf Therapeutics Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2020PTC134938.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹33.5 Lakh. It is led by directors including Vishal Uchila Shishir and Vishwas Uchila Shishir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore Bioinnovation Centres Helix Biotech Park Electronics City Ph1, Karnataka, India – 560100.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.12 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹20.13 Lakh (net margin -328.9%) and EBITDA of -₹20.13 Lakh (EBITDA margin -328.9%).
The company is associated with 1 brand: Cellf.
For more details, the company can be reached via its website cellf.in.
Company Details of Cellf Therapeutics Private Limited
CIN U73100KA2020PTC134938
Registration Number 134938
Incorporation Date 16 June 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Vishal Uchila Shishir Director Vishwas Uchila Shishir Director Vivek Sharma Additional Director Recognitions & Rankings of Cellf Therapeutics
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBangalore Bioinnovation Centres Helix Biotech Park Electronics City Ph1, Karnataka, India – 560100
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Cellf Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Cellf Therapeutics Private Limited
The main business activity of Cellf Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cellf Therapeutics Private Limited FY 2025 filings available
Cellf Therapeutics Private Limited reported revenue of ₹6.12 Lakh (up 920% YoY) for FY 2024.
Revenue · FY 2024
₹6.12 Lakh ▲ 920%
Net loss · FY 2024
₹20.13 Lakh margin -328.9%
EBITDA · FY 2024
-₹20.13 Lakh margin -328.9%
Compounded Annual Growth Rate (CAGR) of Cellf Therapeutics Private Limited
Revenue CAGR growth
1 year
▲ 920%
EBITDA CAGR growth
1 year
▼ 59%
Revenue rose 920% in the latest year. EBITDA fell 59% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Cellf Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹20.13 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹20.13 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Cellf Therapeutics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -328.9% | •••• | •••• | •••• |
| Net Profit Margin | -328.9% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cellf Therapeutics are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cellf Therapeutics Private Limited
Cellf Therapeutics has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Uchila Shishir Also directs: Arivos Ventures LLP, Usr Publishing Home Private Limited, Innaumation Medical Devices Private Limited and 5 more | Director | 16 Jun 2020 | 6 Years 4 Months | Current |
| Vishwas Uchila Shishir Also directs: Usr Publishing Home Private Limited, Xyst Life Sciences Private Limited, Section Infin-8 Foundation and 1 more | Director | 16 Dec 2024 | 1 Years 10 Months | Current |
| Vivek Sharma Also directs: Paintking Unit 3 Private Limited, Neutrino Lifesciences Private Limited, Cellf Lifesciences Private Limited and 1 more | Additional Director | 05 Jun 2025 | 1 Years 4 Months | Current |
| Ashish Dolatrai Desai Also directs: Makers Nest Private Limited, Cellf Lifesciences Private Limited, Apt Global Fincon Private Limited and 1 more | Additional Director | 05 Jun 2025 | 1 Years 4 Months | Current |
Peer Comparison of Cellf Therapeutics Private Limited
Cellf Therapeutics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tensurge Medical System (OPC) Private Limited | ₹6.33 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Bangalore, Karnataka, India |
| B. Ortho International Private Limited | ₹6.24 Lakh (FY 2025) | •••• | •••• | •••• | Ranchi, Jharkhand, India | |
| Protec Concepts Private Limited | ₹6.23 Lakh (FY 2024) | •••• | •••• | 1284.0% | •••• | Mumbai, Maharashtra, India |
| Perfecdent Solutions Private Limited | ₹6.21 Lakh (FY 2019) | •••• | •••• | -78.0% | •••• | Mandya, Karnataka, India |
| La Cross Clinical Products Pvt Ltd | ₹6.2 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Cellf Therapeutics Private Limited this company | ₹6.12 Lakh (FY 2024) | •••• | •••• | 920.0% | •••• | Bangalore, Karnataka, India |
| Rock Stance Private Limited | ₹6.1 Lakh (FY 2025) | •••• | •••• | •••• | Ramanagara, Karnataka, India | |
| Innovative Orthodontic Technologies Private Limited | ₹6.08 Lakh (FY 2020) | •••• | •••• | 82.0% | •••• | Dindigul, Tamil Nadu, India |
| Aakruth Bio-Med Systems Private Limited (OPC) | ₹6.08 Lakh (FY 2016) | •••• | •••• | •••• | Bengaluru, Karnataka, India | |
| 1St Rate Pharma Private Limited | ₹6.05 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Satkar Avenues Private Limited | ₹6 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Cellf Therapeutics by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Cellf Therapeutics Private Limited
Cellf Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cellf Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Cellf Therapeutics.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cellf Therapeutics Private Limited
Cellf Therapeutics Private Limited has 7 board changes on record since 2020: 4 appointments and 3 cessations. The latest: Ashish Dolatrai Desai was appointed as Additional Director on 05 Jun 2025.
AGM
Cellf Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Ashish Dolatrai Desai was appointed as Additional Director.
Appointed
Vivek Sharma was appointed as Additional Director.
Filing
Cellf Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Vishwas Uchila Shishir was appointed as Director.
Ceased
Ganesh Sambasivam ceased to be Director.
Ceased
Gururaj Ananda Rao ceased to be Nominee Director.
Ceased
Jyothsna Ananda Rao ceased to be Nominee Director.
Appointed
Vishal Uchila Shishir was appointed as Director.
Incorporation
16 Jun 2020
Cellf Therapeutics Private Limited was registered on 16 Jun 2020 with Roc Bangalore & aged 6 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Cellf Therapeutics Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cellf Therapeutics Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cellf Therapeutics Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cellf Therapeutics Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cellf Therapeutics Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellf Therapeutics Private Limited
Cellf Therapeutics is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 June 2020 (6+ years old) and is registered under CIN U73100KA2020PTC134938.
Cellf Therapeutics reported revenue of ₹6.12 Lakh for FY 2024 (up 920% YoY).
Cellf Therapeutics has 4 current directors:
- Vishal Uchila Shishir - Director
- Vishwas Uchila Shishir - Director
- Vivek Sharma - Additional Director
- Ashish Dolatrai Desai - Additional Director
Cellf Therapeutics reported a net loss of ₹20.13 Lakh (net margin -328.9%) and EBITDA of -₹20.13 Lakh (EBITDA margin -328.9%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Cellf Therapeutics is U73100KA2020PTC134938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellf Therapeutics was incorporated on 16 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Cellf Therapeutics by revenue are Tensurge Medical System (OPC) Private Limited, B. Ortho International Private Limited, Protec Concepts Private Limited, Perfecdent Solutions Private Limited, La Cross Clinical Products Pvt Ltd and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Ashish Dolatrai Desai was appointed as Additional Director on 05 Jun 2025. Vivek Sharma was appointed as Additional Director on 05 Jun 2025. Vishwas Uchila Shishir was appointed as Director on 16 Dec 2024. Cellf Therapeutics has 7 board changes on record in total.
Yes, Cellf Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Cellf Therapeutics can be reached through the website cellf.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Cellf Therapeutics is at Bangalore Bioinnovation Centres Helix Biotech Park Electronics City Ph1, Karnataka, India – 560100.